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Corrigenda
Erratum
Por questões alheias à nossa vontade a ver-
são em inglês do artigo “Biópsia pulmonar 
cirúrgica em doentes sob ventilação invasi-
va e com suspeita de doença difusa do pa-
rênquima pulmonar/Open lung biopsy in 
patients on mechanical ventilation with sus-
pected diffuse lung disease” (Natália Melo, 
Sandra Figueiredo, António Morais, Con-
ceição Souto Moura, Paulo Pinho, Pedro 
Bastos, Teresa Oliveira) publicado na Rev 
Port Pneumol 2009; XV(4):597-611, veio 
acompanhada de erros importantes que 
desvirtuaram significativamente o original, 
pelo que optamos pela sua nova publica-
ção. Pelo ocorrido, as nossas desculpas aos 
autores.
O editor
Regrettably, the english version of the article 
“Biópsia pulmonar cirúrgica em doentes sob 
ventilação invasiva e com suspeita de doença 
difusa do parênquima pulmonar/Open lung 
biopsy in patients on mechanical ventilation 
with suspected diffuse lung disease” (Natália 
Melo, Sandra Figueiredo, António Morais, 
Conceição Souto Moura, Paulo Pinho, Pe-
dro Bastos, Teresa Oliveira) published in the 
Rev Port Pneumol 2009; XV(4):597-611, 
appeared in a form which contained a num-
ber of errors that detractec significantly from 
the original, and due to the nature of this 
mistake we have decided to re-publish the 
article. We offer our sincere apologies to the 
authors for this unfortunate lapse.
The editor
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Introduction
Open lung biopsy (OLB) is the gold standard 
test for many lung diseases which present with 
acute respiratory failure and diffuse pulmo-
nary infiltrates1. It is, however, an invasive pro-
cedure, and thus employed only when other, 
less invasive, methods have been tried or when 
a precise diagnosis is needed quickly1.
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The available evidence on the safety and di-
agnostic yield of OLB in critically ill pa-
tients on mechanical ventilation (MV) is 
scarce; therefore, the correct indication of 
OLB is difficult to establish in such patients, 
and the available studies disagree about 
whether it is beneficial. Some authors2,3 
consider OLB both safe and diagnostically 
useful, and believe that it influences thera-
peutic decisions, while others4,5 argue that it 
confers no survival benefit and entails ad-
ditional morbidity and mortality. Because 
of these potential drawbacks, many clini-
cians are reluctant to perform OLB in pa-
tients on MV. However, cases of lung dis-
ease of unknown aetiology and refractory to 
empirical treatment require an accurate his-
tological diagnosis so that specific therapy 
can be started.
We aimed to determine the diagnostic yield, 
changes to diagnosis and therapy, complica-
tions, and mortality of OLB performed in 
patients with suspected diffuse lung disease 
on MV.
Material and methods
We performed a retrospective study of the 
clinical files of patients admitted to the 
adult Multidisciplinary Intensive Care Units 
of S. João Hospital between January 1999 
and July 2007 (8.5 years). The inclusion cri-
teria were respiratory failure requiring MV 
and diffuse lung infiltrates for which OLB 
was indicated. Patients who were placed on 
MV after OLB or were biopsied during a 
thoracotomy performed for therapeutic 
purposes were excluded.
The data obtained on the subjects included 
demographic data, comorbidities, suspected 
diagnosis on ICU admission, diagnostic tests 
performed before OLB (including comput-
ed tomography (CT) of the chest and bron-
choscopy), treatment administered prior to 
OLB, PaO2/FiO2 and PEEP levels before 
and after OLB, the histological diagnoses 
obtained and their influence on patient 
management, and complications and mor-
tality associated with the surgical procedure.
All biopsies were performed via thoracoto-
my (mostly minithoracotomy) on sites se-
lected based on imaging abnormalities. A 
maximum of 3 lung tissue samples were 
taken for histological analysis. After lung 
tissue was obtained, all patients had their 
pleural spaces drained using 2 pleural drains, 
which were removed as early as possible if 
there were no air leaks.
Statistical analysis was performed using SPSS 
14.0., with p<0.05 considered significant.
Results
Pre-OLB demographic and clinical data
OLB is seldom performed in our institution, 
with an annual rate of 0.2%-0.6% of patients 
admitted to the ICU at S. João Hospital. 
Nineteen patients met our inclusion criteria. 
Mean patient age was 58±16.3 years, 10 
(53%) were male, 5 (26.3%) were immu-
nodepressed, and 12 (63.2%) had previously 
diagnosed comorbidities. Before the biopsy, 
all patients underwent CT of the chest and 
15 (79%) patients had had fiberoptic bron-
choscopy. When OLB was performed, 12 
(63.2%) patients were on antibiotic therapy, 
14 (73.7%) were receiving steroids, 4 (21.1%) 
were on inotropic support, PEEP (n=16) and 
PaO2/FiO2 (n=18) levels were, on average, 
9 cmH2O and 171 mmHg, respectively. At 
the time of the OLB, patients had stayed on 
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average 13±7 days in the ICU. Duration of 
MV before the procedure was 11.8 days for 
survivors and 14.9 days for non survivors, a 
difference that was not statistically significant 
(p=0.6).
Intra- and peri-operative complications 
and physiological abnormalities
There were no intra-operative complica-
tions. Four patients (21%) developed com-
plications, all of which consisted of persis-
tent air leak lasting 4 to 27 days, and one 
patient required inotropic support after 
OLB. Mean post-OLB PaO2/FiO2 and 
PEEP were 202 mmHg and 8 mmHg, re-
spectively. The levels of these parameters 
were not significantly different before and 
after the biopsy.
Histological diagnoses
The diagnostic yield was 95%. Only one 
patient had an inconclusive diagnosis be-
cause of small sample size. Table I shows the 
histological diagnoses. Diffuse alveolar dam-
age (DAD) (Fig. 1) was the most common 
diagnosis, found in 7 patients, 6 of which 
were in the disease’s fibroproliferative stage 
and 1 in the exudative stage. Two patients 
with no known prior lung pathology had 
abnormalities compatible with DAD on 
histology, as well as features compatible with 
usual interstitial pneumonia. Given these 
findings, acute exacerbation of idiopathic 
pulmonary fibrosis (IPF) was diagnosed af-
ter other causes of IPF decompensation 
were ruled out (Fig. 2).
One female patient, admitted to hospital 
with respiratory insufficiency and pulmo-
nary thromboembolism (PTE), was admit-
ted to the ICU following cardiorespiratory 
arrest (CRA). Imaging abnormalities sug-
gested diffuse lung disease, and an OLB was 
performed because her clinical presentation 
was suspected to be caused by another un-
derlying disease. The biopsy revealed no ab-
normalities other than recent, organised 
thrombus.
The 2 cases of organising pneumonia (OP) 
were associated with Pseudomonas aerugino-
sa infection (1 case) and Legionella infection 
(1 case) (Fig. 3). Two patients were diag-
nosed with eosinophilic pneumonia, and 
one of them underwent a bronchoscopy. 
However, a total and differential cell count 
could not be performed in the bronchoal-
veolar lavage (BAL) because the sample’s 
yield was insufficient. BAL cell counting 
was not performed in the other patient be-
cause the diagnosis was not suspected.
One patient was admitted to the ICU after 
suffering CRA during a fiberoptic bronchos-
copy performed for DLD workup. Since the 
patient still did not have a definitive diagno-
sis, an OLB was performed and the histologi-
cal findings were compatible with sarcoidosis. 
Viral pneumonia was diagnosed by histologi-
cal analysis in one patient and by molecular 
biology techniques (positive test for Cytomeg-
alovirus (CMV) DNA in a lung biopsy frag-
ment) in another. Fungal pneumonia with 
Candida spp. characteristics was diagnosed by 
visualisation of fungal structures and con-
firmed by histochemical methods using PAS, 
PAS-D and Grocott methods.
The impact of the histological diagnosis 
on management and outcomes
The OLB results led to review of the initial 
diagnosis in 14 patients (74%) and influ-
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Table I – Patients enrolled in the study
Diagnosis on admission Diagnosis after OLB Changes to diagnosis
Changes 
to management
Clinical 
course
1 Bilateral pneumonia + septic shock Diffuse alveolar damage Yes Yes Died
2 Diffuse lung disease of unknown aetiology Acute exacerbation of IPF Yes No* Died
3 Lung-kidney syndrome Diffuse alveolar damage Yes No Discharged
4 Vasculitis with lung involvement Diffuse alveolar damage Yes Yes Died
5 PTE + diffuse interstitial infi ltrates PTE No No Discharged
6 Bilateral pneumonia OP Yes Yes Discharged
7 Bilateral pneumonia OP Yes Yes Discharged
8 ARDS Diffuse alveolar damage No No Discharged
9 Severe sepsis + suspected lung-kidney syndrome Unspecifi c abnormalities (small sample) No No Discharged
10 Bilateral pneumonia CMV pneumonia Yes Yes Discharged
11 Severe CAP Acute eosinophilic pneumonia Yes No* Died
12 Severe CAP Eosinophilic pneumonia Yes Yes Discharged
13 Diffuse lung disease of unknown aetiology Acute exacerbation of IPF Yes No* Died
14 Bilateral pneumonia Viral pneumonia  Yes  Yes Died
15 ARDS Diffuse alveolar damage No No Discharged
16 Post CRA + DLD undergoing a workup Sarcoidosis Yes No Discharged
17 ARDS Diffuse alveolar damage No No Died
18 CAP + bilateral pulmonary nodules Fungal pneumonia Yes Yes Died
19 CAP Diffuse alveolar damage Yes No Died
TOTAL 18 (95%) 14 (74%) 8 (42%) 9 (47%)
IPF – idiopathic pulmonary fi brosis; PTE – pulmonary thromboembolism; OP – organising pneumonia; ARDS – acute respiratory distress syndrome; CRA – cardiorespiratory 
arrest; CAP – community acquired pneumonia
* Died before histologic result of OLB was known
B
Fig. 1 – Diffuse alveolar damage. A – Marked interstitial thickening from fi broblast proliferation and a mild mononuclear in-
fl ammatory infi ltrate with distortion of the alveolar spaces (HE 40X). B – Hyaline membranes (HE 400X)
A
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enced management in 8 patients (42%). It 
is important to note that 3 patients died be-
fore the biopsy results became available. 
Overall mortality was 47% (9 patients). Of 
the 10 patients who survived to discharge, 4 
(40%) had their management influenced by 
the biopsy results; of the 9 patients who 
died, 4 (44.4%), had their treatment influ-
enced by the histological diagnosis. Three of 
the 4 patients who developed complications 
died and 1 was discharged from hospital. 
Their deaths were caused by acute exacerba-
tion of IPF, cardiac and pulmonary thrombi 
(autopsy finding) and sepsis with multior-
gan dysfunction.
Discussion
OLB is rarely performed in the ICU. In the 
USA, the annual rate is 0-0.9%6. The deci-
A B
Fig. 2 – Diffuse alveolar damage superimposed on usual interstitial pneumonia. A – Irregular spaces, cystic dilatation and 
mucous content, on a fi brotic background (HE 40X). B – Interalveolar septa show marked thickening due to fi broblast prolif-
eration, which is evidence of an exacerbation (HE 400X)
Fig. 3 – Organising pneumonia. A and B – Intra-luminal fi brosis involving a respiratory bronchiolus and the adjacent alveolar 
spaces. The process is well delimited in relation to the adjacent pulmonary parenchyma (A– HE 40X; B– HE 400X)
A B
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sion to perform the procedure in patients 
on MV depends on the need for an accurate 
diagnosis, which is a prerequisite for start-
ing specific therapy, avoiding the side effects 
of ineffective empirical treatment, and ob-
taining prognostic information6.
In our study, OLB had a diagnostic yield of 
95%, and only one patient remained with-
out a diagnosis because the sample was too 
small. This rate is comparable to that re-
ported in the literature7,8 (> 92%), but it is 
important to point out that an ideal sample 
must have at least 3 cm in its greatest di-
mension and originate from more than one 
lobe9. Despite the similar diagnostic yield10, 
we preferred thoracotomy to videothoras-
copy for biopsy because the former takes 
less time and requires neither replacement 
of the orotracheal tube with a double-lumen 
tube, nor selective ventilation of one lung. 
In addition, the diagnostic yield of OLB in 
patients on MV was similar to that observed 
in a study of outpatients with diffuse lung 
disease referred for OLB, which did not re-
quire prior ventilatory support3,10-13.
While the OLB results led to review of the 
initial diagnosis in 14 patients (74%), it 
only affected the management of 8 (42%) 
cases. This rate is lower than that seen in 
other studies6,11-13 (64 – 75%) and can be 
explained in part by 3 patients having died 
before the biopsy result was known, (2 were 
later diagnosed with acute exacerbation of 
IPF and 1 with eosinophilic pneumonia). 
These diagnoses could have influenced 
treatment and prognosis in all these cases, 
particularly the last one.
Seven patients were diagnosed with DAD. 
In these cases, knowing the DAD stage had 
an important influence on treatment, even 
though histology did not reveal the under-
lying cause, because, as Meduri et al.14 have 
shown, steroids can improve survival in pa-
tients in the fibroproliferative stage. When 
the clinical picture is compatible and there 
is no known predisposing factor to DAD, a 
diagnosis of acute interstitial pneumonia15 
(AIP) is made. Some patients in this study 
could have AIP, but infectious causes could 
not be definitely ruled out because the bi-
opsy fragments were not subjected to ex-
haustive microbiology studies, particularly 
virology assays.
The time interval between ICU admission 
on MV and the OLB (mean 13 days) was 
greater than in other similar studies13,16,17 (3 
– 8 days). The impact of the duration of 
MV before lung biopsy on clinical outcomes 
has not been established. Some authors, 
however, suggest that early OLB is advanta-
geous. Warner et al.5 reported that time in-
terval between the onset of respiratory fail-
ure and performance of OLB was 
significantly shorter in survivors (4.4±2.9 
days) than in non survivors (6.1±3.6 days). 
In the study by Lim et al.16, patients who 
underwent OLB within a week of starting 
MV had a greater chance of survival (63% 
vs. 11%; p=0.018), even though there were 
no differences in MV time between the sur-
vivors and non survivors group. Araby et 
al.18, however, found no difference in time 
on MV before biopsy in survivors and non 
survivors. We found no significant differ-
ence in time on MV prior to biopsy in sur-
vivors and non survivors either (11.8 days 
vs. 14.9 days; p=0.6).
There were no significant differences in the 
levels of PEEP and PaO2/FiO2 before and 
after OLB, and only one patient needed 
OLB inotropic support after OLB. There-
fore, we concluded that this surgical proce-
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dure did not cause any significant ventila-
tory or haemodynamic disturbances.
The complications associated with this proce-
dure in patients on MV vary considerably 
from study to study, probably because the 
populations studied are heterogeneous. The 
most common complication is persistent air 
leak6,11,12,17, with rates as high as 42%18. Other, 
less common, complications include hae-
mothorax11,17, empyema2,11, wound infection2 
and intra-operative hypotension6,16. In the 
present study, 4 (21%) patients developed 
complications. All of them were treated for 
persistent air leakage. Cho et al.19 studied the 
risk factors for persistent air leak in patients on 
MV with ARDS who underwent OLB. Peak 
airway pressure (Ppeak) was the only predic-
tive factor identified (risk of persistent air leak 
was reduced by 42% for each 5 cmH2O re-
duction in Ppeak); therefore, protective venti-
latory strategies which limit the Ppeak are 
strongly associated with a lower risk of persis-
tent air leak in the post-operative period. Since 
our study had a small patient population and 
few complications, the effects of Ppeak on the 
risk of air leak could not be determined.
Overall mortality was 47%, similar to that 
reported in other studies3,6,11-13,16-18 (46% – 
67%). Procedure-related mortality is ex-
tremely low, even in patients on MV3,6,11-13,16-
18. Fatalities caused by cardiac arrest17, 
haemorrhage6 and hypertensive pneumotho-
rax6 have been described. There were no bi-
opsy-related deaths in our study.
This study has several limitations, such as 
its retrospective methodology, small sample 
size and sample heterogeneity, as well as se-
lection bias. While a prospective, ran-
domised trial could supply more feasible 
conclusions, such studies are difficult to 
perform in critical patients.
An analysis of this sample suggests that OLB 
is useful in patients on MV with DLD of 
unknown aetiology because of its high diag-
nostic yield and low incidence of ventilatory 
and haemodynamic complications. More-
over, early OLB may improve outcomes fur-
ther in some patients.
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